Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAgronomics Regulatory News (ANIC)

Share Price Information for Agronomics (ANIC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.55
Bid: 8.50
Ask: 8.60
Change: -0.46 (-5.31%)
Spread: 0.10 (1.176%)
Open: 8.45
High: 8.56
Low: 8.20
Prev. Close: 8.66
ANIC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IsraFirst Regulatory Approval for Cultivated Beef

18 Jan 2024 07:00

RNS Number : 0724A
Agronomics Limited
18 January 2024
 

 

 18 January 2024

 Agronomics Ltd

("Agronomics" or the "Company")

 Israel Awards the World's First Regulatory Approval for Cultivated Beef

 

Agronomics (LON: ANIC), a leading listed company in cellular agriculture, is pleased to announce that the Israeli Ministry of Health (IMOH) has granted regulatory approval for the world's first commercial sale of cultivated beef.

Agronomics would like to congratulate Aleph Farms on becoming the first company in the world to gain regulatory approval for its cultivated beef product after the IMOH issued a 'no questions' letter, which allows the company to commercialise its products in Israel. Aleph Farms has also filed for regulatory approval in Singapore, Switzerland, the UK and the US, and is advancing its applications in other markets.

Agronomics is aware of multiple companies, including those within its portfolio, that are expecting regulatory approvals for cultivated meat and seafood products across several markets. Meanwhile, Vow Food is in the middle of a consultation process after its cultured quail was cleared as safe to eat by Food Standards Australia and New Zealand in December 2023. 

These announcements follow Upside Foods and Good Meat, which received regulatory approval for their cultivated chicken products in the US last year.

Jim Mellon, Executive Chairman of Agronomics commented:

"This approval is another significant step forward for our industry and shows the commitment among an increasing number of jurisdictions to find more sustainable production methods to meet the increasing global demand for protein. We look forward to seeing some of Agronomics' portfolio companies achieving this significant milestone in the near future."  

About Agronomics

Agronomics is a leading listed alternative proteins company with a focus on cellular agriculture and cultivated meat. The Company has established a portfolio of 24 companies in this rapidly advancing sector. It seeks to secure minority stakes in companies owning technologies with defensible intellectual property that offer new ways of producing food and materials with a focus on products historically derived from animals. These technologies are driving a major disruption in agriculture, offering solutions to improve sustainability, as well as addressing human health, animal welfare and environmental damage. This disruption will decouple supply chains from the environment and animals, as well as being fundamental to feeding the world's expanding population. A full list of Agronomics' portfolio companies is available at https://agronomics.im/.

 

About Cellular Agriculture

Cellular Agriculture is the production of agriculture products directly from cells, as opposed to raising an animal for slaughter, or growing crops. This encompasses cell culture to produce cultivated meat and materials, and fermentation processes that harness a combination of molecular biology, synthetic biology, tissue engineering and biotechnology to massively simplify production methods in a sustainable manner.

 

Over the coming decades, the source of the world's food supply traditionally derived from conventional agriculture is going to change dramatically. We have already witnessed the first wave of this shift with the consumer adoption of plant-based alternative proteins but today, we are on the cusp of an even bigger wave of change. This is being facilitated by advances in cellular agriculture. This change is necessary, given scientists claims that if we maintain existing animal protein consumption patterns, then we will not meet the Paris Agreement's goal of limiting warming to 1.5?.

 

AT Kearney, a global consultancy firm, projects that cultivated meat's market share will reach 35% by 2040. This combined with the Good Food Institute's estimate that a US $1.8 trillion investment will be required in order to produce just 10% of the world's protein using this technology, means that we are on the cusp of a multi-decade flow of capital to build out manufacturing facilities. Funding in the field of cellular agriculture is accelerating, however still less than US$ 5 billion has been invested worldwide since the industry's inception in 2016.

 

For further information please contact:

Agronomics

Limited

Beaumont

Cornish Limited

Canaccord Genuity Limited

Cavendish Securities Plc

Peterhouse Capital

Limited

SEC Newgate

The Company

Nomad

Joint Broker

Joint Broker

Joint Broker

Public Relations

Jim Mellon

Denham Eke

Roland Cornish

James Biddle

Andrew Potts

Harry Pardoe

Alex Aylen (Head of Equities)

Giles Balleny

Michael Johnson

Lucy Williams

Charles Goodfellow

Ed Orlebar

Alistair Walker

+44 (0) 1624 639396

info@agronomics.im

+44 (0) 207 628 3396

+44 (0) 207 523 8000

+44 (0) 207 397 8900

+44 (0) 207 469 0936

+44 (0) 20 7930 0777

+44 (0) 7738 724 630

agronomics@tbcardew.com

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAMZGMMLNZGDZM
Date   Source Headline
18th Jul 20237:00 amRNSFormo Successful Tasting Event
18th Jul 20237:00 amRNSPortfolio Company Update: Galy Co. Update
11th Jul 202311:33 amRNSExercise of Warrants and TVR
22nd Jun 20231:06 pmRNSCultivated Meat Approved for Sale in the US
22nd Jun 202312:42 pmRNSPortfolio Company CellX Raises US$ 6.5 million
22nd Jun 202310:00 amRNSGood Dog Food raises investment from Pets at Home
16th Jun 20237:00 amRNSUSDA Gives First Label Approval to Lab Grown Meat
15th Jun 20237:00 amRNSAUD 2.5 million investment in HydGene Renewables
14th Jun 20237:00 amRNSAgronomics Appoints Comms Consultancy
1st Jun 20237:00 amRNSReplacement Warrant Final Exercise Dates Extension
31st May 20237:00 amRNSExtension of Warrant Final Exercise Dates
9th May 20232:08 pmRNSDirectors' Dealings
4th May 20237:00 amRNSInvestee Company Update: Good Dog Food
2nd May 202311:38 amRNSNet Asset Value calculation as at 31 March 2023
14th Apr 202310:19 amRNSExercise of Warrants and TVR
12th Apr 202312:00 pmRNSInvestee Company Update: Liberation Labs
28th Mar 20237:00 amRNSDirector/PDMR Shareholding
27th Mar 202311:50 amRNSDirector/PDMR Shareholding
16th Mar 20237:00 amRNSFood Fermentation Europe launches
15th Mar 20237:00 amRNSDirectors’ interests in shares
10th Mar 20237:15 amRNSEdison issues update on Agronomics (ANIC)
2nd Mar 20235:50 pmRNSHolding(s) in Company
23rd Feb 20238:00 amRNSANIC invests in Wild Microbes US$3.3m Financing
23rd Feb 20237:00 amRNSAgronomics Welcomes Marisa Drew as a Director
20th Feb 20237:00 amRNSPrecision Fermentation Alliance Formed
9th Feb 20239:00 amRNSAgronomics February 2023 Newsletter
8th Feb 20237:00 amRNSUnaudited Interim Results
7th Feb 20234:49 pmRNSInvestee Company Update: CellX
2nd Feb 202311:04 amRNSResult of AGM
25th Jan 20237:00 amRNSNet Asset Value calculation at 31 December 2022
25th Jan 20237:00 amRNSInvestee company Update: Liberation Labs
4th Jan 20237:00 amRNSPerformance Shares issued to Shellbay Investments
30th Dec 202212:00 pmRNSPortfolio Company Update: Liberation Labs
23rd Dec 20227:00 amRNSSolar Foods receives Euro34 million in grant
20th Dec 20229:00 amRNSFinal Results
5th Dec 20229:18 amRNSInvestee Company Update: Clean Food Group
5th Dec 20227:00 amRNSFurther Investment in Liberation Labs Seed Round
28th Nov 20227:00 amRNSHolding(s) in Company
23rd Nov 20225:59 pmRNSHolding(s) in Company
17th Nov 20227:30 amRNSFirst Cultivated Meat Company gets FDA approval
3rd Nov 20227:00 amRNSAgronomics Capital Markets Day 3rd November
27th Oct 202212:02 pmRNSDirector Dealings
26th Oct 20229:30 amRNSPortfolio Company Solar Foods Update
20th Oct 20227:00 amRNSInvestment in Liberation Labs US$ 20m fundraise
19th Oct 20229:00 amRNSAgronomics October 2022 Newsletter
19th Oct 20227:00 amRNSNet Asset Value calculation to 30 September 2022
12th Oct 20228:53 amRNSHolding(s) in Company
11th Oct 20227:00 amRNSExercise of Warrants & TVR
10th Oct 20227:00 amRNSPortfolio Company Meatable Update
6th Oct 20227:00 amRNSPortfolio Company VitroLabs Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.